patient
occup
activ
level
expect
determin
mostli
decis
anterior
cruciat
ligament
acl
reconstruct
even
sedentari
patient
will
modifi
activ
consid
nonop
treatment
injuri
result
increas
risk
menisc
chondral
lesion
subsequ
high
possibl
earli
cartilag
degener
consequ
acl
reconstruct
method
choic
specif
chronolog
age
contraind
numer
annual
perform
world
activ
patient
acl
reconstruct
provid
excel
chanc
return
preinjuri
activ
use
autolog
graft
popular
mani
clinic
studi
report
good
result
howev
mani
second
thought
avoid
autogen
tissu
sacrific
reduc
donorsit
morbid
although
patellar
tendon
becom
common
graft
sourc
acl
reconstruct
bonepatellar
tendonbonebptb
autograft
signific
complic
donor
site
quadricep
weak
patellofemor
pain
loss
rang
motion
rom
patella
fractur
patellar
tendon
patella
infera
syndrom
earli
cartilag
degen
chang
arthrofibrosi
hand
hamstr
autograft
semitendinosu
gracili
also
popular
graft
option
function
result
similar
bptb
without
extensor
mechan
deficit
howev
report
disadvantag
includ
knee
flexor
strength
variabl
hamstr
size
fixat
limit
delay
incorpor
reason
surgeon
tri
limit
signific
morbid
associ
autograft
harvest
use
allogen
tissu
cadav
emerg
excel
option
howev
acl
reconstruct
allograft
carri
specif
problem
therefor
dilemma
decid
graft
type
advantag
donorsit
morbid
import
allograft
use
addit
allograft
offer
larger
graft
size
could
order
low
incid
shorter
oper
time
improv
overal
qualiti
life
howev
consider
disadvantag
includ
cost
slower
graft
embodi
potenti
diseas
transmiss
bacteri
viral
prion
thu
optim
graft
choic
still
matter
debat
one
say
optim
graft
abl
reproduc
anatomi
biomechan
nativ
acl
incorpor
rapidli
provid
strong
initi
fixat
caus
low
donorsit
morbid
chapter
review
literatur
use
allograft
acl
reconstruct
report
experiment
clinic
comparison
studi
usual
allograft
acl
reconstruct
patellar
ligament
achil
tendon
tibiali
anterior
posterior
use
peroneu
longu
hamstr
fascia
lata
also
report
one
studi
report
ultim
failur
load
doubl
tibiali
anterior
tibiali
posterior
peroneu
longu
n
respect
valu
almost
higher
usual
failur
load
current
describ
acl
graft
sourc
anoth
studi
recommend
use
soft
tissu
allograft
tibiali
anterior
tendon
doubl
stg
rather
allograft
bone
plug
bptb
achil
tendon
attribut
slow
incorpor
allograft
bone
plug
greater
crosssect
area
avail
soft
tissu
allograft
fact
soft
tissu
graft
readili
avail
sinc
donor
provid
six
soft
tissu
four
bone
plug
graft
anoth
issu
surgeon
take
account
possibl
graftconstruct
mismatch
order
obvious
relat
bptb
allograft
exampl
graft
tall
donor
use
shorter
patient
reason
better
provid
bone
bank
inform
recipi
height
length
paramet
graft
order
avoid
possibl
signific
graftconstruct
mismatch
main
concern
patient
famili
physician
case
allograft
acl
reconstruct
possibl
viral
bacteri
infect
human
immunodefici
viru
hiv
hepat
b
hbv
c
hcv
virus
human
tcell
leukemia
viru
htlv
syphili
aerob
anaerob
bacteria
main
pathogen
implic
allograft
infect
recent
addit
concern
rais
newli
emerg
pathogen
west
nile
viru
sever
acut
respiratori
syndrom
sar
coronaviru
prion
associ
transmiss
spongiform
encephalopathi
diseas
center
diseas
control
prevent
cdc
defin
allograftassoci
infect
one
occur
first
year
implant
patient
known
risk
factor
otherwis
healthi
bacteri
fungal
infect
commonli
emerg
sign
inflamm
infect
near
oper
site
posit
wound
blood
cultur
necessari
confirm
diagnosi
viral
parasit
infect
follow
symptom
sign
characterist
infecti
agent
eg
fever
lymphadenopathi
weak
posit
serolog
molecular
test
result
diseas
transmiss
allograft
transplant
occur
two
differ
way
first
way
transmiss
infect
donor
result
occult
perimortem
infect
prolong
tissu
recoveri
time
donor
screen
failur
infecti
agent
may
also
come
breakdown
donor
gastrointestin
respiratori
system
second
way
contamin
healthcar
provid
tissu
procur
steril
preserv
procedur
gener
risk
diseas
transmiss
depend
mainli
tissu
type
prepar
method
definit
data
avail
regard
risk
diseas
transmiss
allograft
tissu
transplant
believ
event
usual
underreport
difficult
confirm
surveil
advers
effect
diseas
transmiss
incid
allograft
implant
occur
countri
voluntari
basi
buck
et
al
estim
risk
hiv
transmiss
infect
donor
transplant
tissu
approxim
risk
contract
hepat
b
c
estim
much
higher
due
greater
preval
hepat
gener
popul
current
donor
screen
steril
preserv
techniqu
diminish
possibl
distribut
allograft
materi
donor
activ
viral
infect
concern
remain
howev
regard
initi
window
period
viral
antigen
antibodi
level
may
detect
despit
infect
applic
advanc
serolog
test
nucleic
acid
test
manag
decreas
window
period
approxim
day
hiv
hcv
day
hbv
infect
risk
implant
tissu
hivposit
donor
current
estim
one
one
one
million
risk
implant
hcvinfect
tissu
estim
bacteri
infect
follow
acl
reconstruct
anoth
import
concern
sever
report
infect
follow
allograft
transplant
cdc
report
total
case
bacteri
infect
associ
musculoskelet
allograft
half
case
involv
contamin
clostridium
speci
eight
report
infect
occur
acl
reconstruct
use
tendon
allograft
barbour
et
al
report
four
addit
case
clostridium
septicum
infect
acl
reconstruct
case
diseas
transmiss
attribut
tissu
process
condit
postop
infect
rate
follow
autograft
allograft
acl
reconstruct
investig
two
larg
retrospect
studi
william
et
al
indelli
et
al
review
acl
reconstruct
respect
infect
rate
found
respect
signific
differ
infect
rate
autograft
allograft
reconstruct
recent
studi
katz
et
al
also
fail
find
higher
deep
infect
rate
allograft
compar
autograft
acl
reconstruct
advent
advanc
steril
method
disinfect
musculoskelet
allograft
bacteria
practic
ensur
tissu
prepar
procedur
divid
sever
success
step
first
step
prevent
infect
tissu
enter
donat
pool
care
donor
select
second
step
prevent
contamin
ensur
asept
graft
procur
process
third
step
elimin
residu
infecti
agent
accomplish
tissu
process
final
steril
appropri
donor
select
one
primari
way
prevent
diseas
transmiss
allograft
tissu
bank
accept
donor
year
age
import
step
care
histori
identif
risk
factor
data
concern
communic
diseas
histori
high
risk
behavior
intraven
drug
use
travel
histori
area
high
infect
rate
obtain
surviv
famili
member
medic
blood
donat
record
physic
examin
even
autopsi
report
next
step
test
activ
infect
howev
window
period
detect
antibodi
viral
antigen
still
limit
effect
serolog
test
even
modern
nucleic
acid
test
use
tissu
accredit
donor
procur
asept
environ
standard
oper
room
techniqu
use
includ
prep
drape
time
harvest
also
import
reduc
risk
infect
time
limit
tissu
bank
h
bodi
kept
room
temperatur
h
bodi
refriger
howev
asept
recov
tissu
consid
steril
therefor
recov
tissu
usual
undergo
chemic
soak
biolog
deterg
antibiot
antisept
solut
reduc
bioburden
solut
mostli
effect
surfac
contamin
sinc
lack
tissu
penetr
surfac
swab
cultur
also
commonli
perform
examin
presenc
bacteria
fungi
sensit
swab
cultur
found
rang
best
consequ
suggest
cultur
use
evid
steril
monitor
previous
valid
steril
procedur
human
tissu
graft
steril
use
method
appli
implant
medic
devic
particular
complex
threedimension
structur
increas
tissu
densiti
musculoskelet
graft
make
difficult
reagent
penetr
tissu
elimin
pathogen
ideal
steril
process
provid
diseasefre
graft
preserv
mechan
properti
incorpor
characterist
graft
addit
reagent
use
penetr
adequ
tissu
safe
remov
tissu
without
residu
tissu
bank
current
use
mani
differ
proprietari
process
protocol
achiev
success
disinfect
steril
allograft
protocol
date
shown
superior
government
agenc
fda
usa
dictat
protocol
use
fda
howev
requir
tissu
bank
posit
prove
efficaci
steril
process
use
valid
data
process
remov
contamin
allograft
tissu
call
disinfect
steril
defin
process
kill
form
life
includ
microorgan
effect
steril
procedur
express
steril
assur
level
sal
measur
likelihood
viabl
pathogen
exist
allograft
tissu
current
tissu
bank
attempt
reach
sal
accord
standard
set
american
tissu
bank
aatb
two
main
process
steril
irradi
proprietari
chemic
process
ethylen
oxid
eo
industri
fumig
origin
use
steril
medic
devic
introduc
musculoskelet
allograft
process
eo
excel
extern
steril
properti
penetr
tissu
adequ
howev
studi
acl
allograft
process
eo
shown
poor
result
high
rate
intraarticular
reaction
record
includ
persist
effus
chronic
synov
bone
dissolut
ultim
graft
failur
host
tissu
reaction
caus
chemic
residu
left
moist
tissu
consid
respons
find
also
suggest
agent
carcinogen
although
evid
eo
process
allograft
induc
cancer
use
eo
treat
allograft
current
recommend
acl
reconstruct
gammairradi
proven
effect
steril
two
differ
mechan
gener
free
radic
direct
destruct
organ
genom
dose
kgi
requir
neutral
hiv
bptb
allograft
bacteria
elimin
lower
dose
studi
howev
indic
dosedepend
effect
irradi
biomechan
properti
graft
dose
low
kgi
shown
alter
significantli
tensil
strength
acl
reconstruct
allograft
mechan
may
occur
well
understood
possibl
collagen
structur
affect
free
radic
product
studi
suggest
dose
less
kgi
effect
acl
reconstruct
outcom
gammairradi
dose
tissu
bank
current
use
rang
kgi
vivo
studi
compar
irradi
nonirradi
allograft
shown
disappoint
result
studi
underw
achil
tendon
allograft
acl
reconstruct
found
significantli
higher
failur
rate
irradi
dose
kgi
compar
nonirradi
group
respect
similar
trend
confirm
goat
model
studi
patellar
tendon
acl
reconstruct
irradi
kgi
nonirradi
allograft
differ
two
group
record
stiff
maximum
forc
maximum
stress
materi
properti
recent
pretreat
tissu
radioprotect
scaveng
introduc
attempt
block
activ
free
radic
structur
damag
caus
irradi
studi
shown
bone
tendon
allograft
irradi
high
dose
kgi
pretreat
radioprotect
demonstr
preimplant
properti
similar
convent
irradi
nonirradi
allograft
allograft
tissu
preserv
three
differ
method
deep
freshfreez
freezedri
cryopreserv
deep
freez
simplest
wide
use
techniqu
tissu
store
control
freez
temperatur
least
allow
preserv
year
method
effect
strength
graft
shown
reduc
graft
antigen
destroy
class
ii
major
histocompat
protein
freezedri
also
commonli
use
involv
dehydr
graft
freez
vacuum
residu
water
content
level
less
therefor
graft
need
rehydr
least
min
implant
especi
contain
bone
block
along
soft
tissu
viral
load
infect
tissu
decreas
subinfecti
level
method
although
argu
report
graft
antigen
also
reduc
freezedri
method
allow
storag
room
temperatur
year
howev
time
interv
procur
implant
posit
correl
allograft
failur
rate
acl
reconstruct
thu
question
shelf
life
freezedri
tissu
clinic
result
freezedri
allograft
success
overal
although
slightli
better
result
report
freshfrozen
allograft
third
method
tissu
preserv
cryopreserv
employ
control
rate
freez
cryoprotect
media
shown
known
advantag
freshfreez
incur
consider
higher
cost
signific
differ
surgic
techniqu
use
allograft
popular
type
allograft
freshfrozen
requir
rehydr
good
result
clinic
basic
scienc
research
also
allow
use
ident
instrument
autograft
allograft
procedur
boneblock
like
bptb
graft
excel
bonetobon
heal
rigid
interfer
fixat
graft
thaw
evalu
anesthesia
confirm
acl
defici
place
directli
warm
salin
solut
becom
edemat
hypertrophi
best
thaw
keep
tendon
plastic
bag
solut
altern
thaw
graft
begin
diagnost
arthroscopi
confirm
acl
ruptur
thaw
allograft
evalu
confirm
tissu
integr
qualiti
soft
tissu
size
length
diamet
measur
record
patella
tendon
central
third
harvest
similarli
autograft
harvest
avoid
splinter
care
taken
avoid
forcibl
lever
bone
plug
bed
soft
tissu
graft
use
thaw
process
rest
acl
reconstruct
techniqu
step
almost
use
autograft
doublebundl
techniqu
soft
tissu
allograft
popular
tibiali
anterior
posterior
provid
excel
graft
sourc
surgic
process
final
function
result
major
factor
contribut
success
allograft
implant
steril
reduct
antigen
preserv
biomechan
biolog
properti
graft
allograft
antigen
base
class
ii
antigen
encod
gene
major
histocompat
complex
antigen
epitop
may
present
donor
cell
ligament
bone
compon
also
insid
matrix
allograft
fresh
cryopreserv
allograft
contain
viabl
donor
cell
like
elicit
host
immun
respons
deepfrozen
freezedri
allograft
rel
hypocellular
howev
also
shown
caus
detect
immun
respons
tlymphocyt
cellmedi
respons
princip
mechan
host
reject
may
often
mimic
infect
mechan
failur
clinic
consequ
respons
current
unknown
allograft
gener
heal
manner
autograft
donor
cell
death
follow
inflamm
revascularizationrepopul
final
remodel
graft
case
deepfrozen
freezedri
allograft
donor
cell
death
alreadi
occur
implant
tendon
allograft
heal
format
fibrovascular
scar
tissu
grafttunnel
interfac
follow
format
sharpey
fiber
new
bone
product
bone
block
contain
allograft
first
undergo
osteonecrosi
follow
incorpor
graft
surround
host
bone
intraarticular
part
graft
act
scaffold
host
cell
repopul
graft
occur
infrapatellar
fat
pad
distal
posterior
synovi
tissu
proxim
final
collagen
remodel
involv
replac
origin
largediamet
fibril
smallerdiamet
one
incorpor
rate
graft
tissu
may
import
consider
determin
graft
choic
rehabilit
protocol
time
return
play
compar
autograft
allograft
found
demonstr
prolong
inflammatori
respons
greater
decreas
structur
mechan
properti
slower
rate
biolog
incorpor
implant
allogen
tendon
also
demonstr
slower
onset
rate
revascular
greater
bone
tunnel
enlarg
observ
allograft
acl
reconstruct
may
also
suggest
suboptim
heal
allograft
tissu
although
allograft
seem
lose
timezero
strength
remodel
associ
poorer
prognosi
gener
conclus
allograft
seem
heal
pattern
slower
rate
autograft
true
prospect
random
clinic
trial
autograft
versu
allograft
acl
reconstruct
difficult
graft
choic
influenc
patient
age
activ
level
comorbid
preoper
evalu
well
surgeon
prefer
experi
patient
inform
possibl
risk
benefit
option
addit
specif
limit
includ
sever
differ
score
scale
differ
kind
patient
differ
prognos
differ
surgeon
rehabilit
last
year
intern
literatur
publish
clinic
compar
studi
allograft
autograft
use
acl
reconstruct
tabl
report
littl
differ
longterm
basi
howev
studi
report
high
ruptur
rate
postop
allograft
other
suggest
use
allograft
reduc
due
increas
laxiti
time
also
import
say
compar
studi
use
allograft
boneblock
mostli
bptb
signific
lack
comparison
soft
tissu
allo
autograft
would
extrem
use
evalu
doublebundl
techniqu
specif
review
metaanalys
literatur
move
accept
use
allograft
tissu
much
favor
unfavor
present
autograft
graft
choic
routin
acl
reconstruct
allograft
better
reserv
multipl
ligamentinjur
knee
extra
tissu
may
requir
anoth
review
acl
reconstruct
bptb
autograft
favor
bptb
allograft
graft
ruptur
hop
test
paramet
howev
latter
studi
irradi
chemic
process
allograft
exclud
result
significantli
differ
two
graft
type
earli
lephart
et
al
look
activ
male
patient
mean
age
year
acl
reconstruct
month
earlier
use
bptb
autograft
n
allograft
n
retrospect
compar
quadricep
strength
function
recoveri
found
signific
differ
group
either
paramet
conclud
harvest
central
third
patellar
tendon
diminish
quadricep
strength
demand
activ
patient
intens
rehabilit
howev
studi
retrospect
report
select
criteria
group
period
sademmi
et
al
retrospect
report
result
patient
autograft
allograft
patient
underw
arthroscop
bptb
acl
reconstruct
analyz
group
regard
hospit
stay
swell
thigh
atrophi
laxiti
strength
endur
rang
motion
patellofemor
symptom
complic
minimum
followup
year
found
signific
differ
group
regard
periop
morbid
clinic
imag
one
traumat
ruptur
group
two
allograft
patient
demonstr
persist
effus
statist
signific
p
studi
limit
retrospect
design
small
sampl
n
addit
subject
function
evalu
descript
group
characterist
activ
level
shino
et
al
evalu
patient
acl
reconstruct
month
patient
receiv
bptb
autograft
freshfrozen
allograft
found
anterior
laxiti
knee
extensor
torqu
significantli
better
allograft
group
howev
consider
limit
includ
subject
rate
success
also
allograft
group
includ
acut
case
less
meniscectomi
autograft
group
final
patient
cast
immobil
day
difficult
gener
result
current
use
aggress
rehabilit
recent
harner
et
al
review
clinic
result
year
patient
allograft
bptb
acl
reconstruct
patient
autograft
bptb
acl
reconstruct
detail
symptom
activ
level
function
outcom
physic
examin
instrument
knee
laxiti
record
signific
differ
found
extens
loss
higher
autograft
group
ultim
conclus
studi
signific
clinic
differ
outcom
patient
underw
autograft
allograft
bptb
acl
reconstruct
although
studi
detail
methodolog
longterm
followup
also
limit
includ
rehabilit
program
less
aggress
one
commonli
use
today
importantli
group
ident
allograft
group
acut
injuri
compar
autograft
group
period
retrospect
studi
favor
use
allograft
primari
acl
reconstruct
seventyeight
patient
examin
month
follow
acl
reconstruct
bptb
autograft
patient
allograft
patient
import
two
group
match
demograph
detail
age
year
activ
level
time
injuri
surgeri
associ
injuri
type
fixat
use
tibial
femor
side
signific
differ
report
group
subject
result
joint
effus
knee
tender
rang
motion
patellofemor
score
laxiti
knee
muscl
strength
quadricep
atrophi
author
howev
record
two
trend
potenti
signific
eighti
percent
autograft
versu
allograft
recipi
achiev
goodtoexcel
restor
anteroposterior
stabil
mm
sidetosid
laxiti
differ
patient
allograft
group
show
favor
result
concentr
peak
extens
torqu
four
traumat
ruptur
allograft
group
averag
month
po
reason
author
conclud
autograft
bptb
first
choic
acl
reconstruct
allograft
tissu
prefer
graft
choic
use
autolog
tissu
contraind
knee
multipl
ligament
injuri
although
studi
well
design
bias
onethird
patient
lost
followup
random
prospect
nonrandom
studi
two
group
patient
underw
acl
reconstruct
bptb
allograft
autograft
follow
year
year
differ
pain
give
way
motion
patellofemor
crepitu
group
well
match
characterist
acut
injuri
autograft
group
allograft
group
author
conclud
bptb
autograft
allograft
acl
reconstruct
produc
statist
similar
result
year
allograft
accept
choic
primari
acl
reconstruct
howev
use
valid
questionnair
function
score
anoth
prospect
studi
victor
et
al
follow
patient
acl
reconstruct
use
bptb
autograft
allograft
found
signific
differ
group
thigh
muscl
strength
knee
anterior
laxiti
function
score
oneleg
hop
test
knee
swell
quadricep
atrophi
interestingli
allograft
group
show
slightli
greater
quadricep
strength
reduc
anterior
knee
laxiti
month
month
paramet
better
autograft
group
although
evalu
show
signific
trend
increas
laxiti
time
allograft
group
author
conclud
allograft
recommend
stabil
deterior
time
year
quadricep
strength
return
normal
follow
autograft
aclr
kleipool
et
al
prospect
follow
patient
underw
acl
reconstruct
either
freshfrozen
bptb
allograft
patient
autograft
patient
patient
similar
age
activ
level
associ
injuri
addit
preoper
examin
reveal
wors
lachman
anterior
drawer
test
allograft
group
mean
followup
year
normal
nearli
normal
ikdc
scale
achiev
autograft
group
allograft
group
lysholm
score
averag
autograft
group
allograft
group
differ
lachman
anterior
drawer
pivotshift
oneleg
hop
test
sidetosid
laxiti
detect
group
mildtomoder
anterior
knee
pain
found
autograft
allograft
recipi
main
conclus
bptb
allograft
good
altern
acl
reconstruct
recent
peterson
et
al
compar
prospect
nonrandom
trial
bptb
allograft
bptb
autograft
mean
followup
month
patient
assess
lysholm
tegner
score
swell
pain
rang
movement
crepitu
laxiti
use
differ
addit
increas
knee
stretch
allograft
group
year
po
although
author
explain
exclus
criteria
choos
patient
total
conclud
use
allograft
accept
choic
acl
reconstruct
chang
et
al
retrospect
review
patient
bptb
allograft
bptb
autograft
minimum
followup
period
one
surgeon
perform
reconstruct
case
augment
iliotibi
band
tenodesi
found
signific
differ
subject
score
lachman
pivot
shift
test
knee
anterior
laxiti
crepitu
atrophi
joint
effus
allograft
group
three
traumat
ruptur
nonsignificantli
higher
incid
anterior
knee
pain
significantli
higher
incid
flexion
deficit
although
basi
result
author
suggest
autograft
bptb
remain
gold
standard
allograft
remain
reason
altern
howev
allograft
group
older
greater
preoper
laxiti
higher
rate
medial
tibial
plateau
chondral
lesion
contrari
kusto
et
al
retrospect
nonrandom
trial
conclud
bptb
allograft
good
altern
autograft
offer
patient
altern
graft
choic
compar
patient
bptb
autograft
patient
allograft
patient
young
year
mean
followup
month
independ
examin
check
lysholm
knee
score
scale
tegner
activ
score
ikdc
knee
ligament
evalu
form
differ
score
studi
signific
limit
data
patient
characterist
apart
age
gender
report
associ
injuri
barrett
et
al
record
result
patient
year
older
least
year
followup
bptb
autograft
allograft
acl
reconstruct
differ
selfreport
questionnair
tegner
activ
lysholm
score
ikdc
function
level
normal
nearli
normal
patient
allograft
group
patient
autograft
group
sidetosid
differ
mm
allograft
group
mm
autograft
group
interestingli
patient
allograft
group
return
earlier
activ
author
conclud
graft
choic
highli
effect
poehl
et
al
compar
prospect
patient
freezedri
achil
tendon
allograft
without
boneblock
bptb
autograft
year
followup
averag
year
subject
measur
year
object
measur
patient
evalu
preoper
postop
week
week
month
month
annual
year
object
outcom
measur
includ
measur
rang
motion
quadricep
atrophi
ikdc
score
subject
patient
complet
five
questionnair
document
function
statu
pain
healthrel
qualiti
life
result
led
conclus
despit
differ
graft
type
fixat
treat
surgeon
similar
longterm
result
stabil
function
achiev
bptb
autograft
achil
tendon
allograft
reconstruct
acl
howev
patient
treat
allograft
reconstruct
less
pain
function
limit
earli
postop
period
rihn
al
review
retrospect
result
patient
bptb
autograft
acl
reconstruct
patient
bptb
allograft
steril
mrad
irradi
averag
year
followup
report
allograft
group
significantli
older
year
versu
year
longer
delay
injuri
surgeri
week
versu
week
differ
ikdc
subject
knee
score
allograft
versu
autograft
clinic
evalu
record
signific
differ
patellofemor
symptom
rang
motion
vertic
jump
singleleg
hop
test
allograft
group
slightli
improv
sidetosid
pivotshift
result
reduc
maximum
manual
sidetosid
differ
conclud
similar
patientreport
object
outcom
obtain
autograft
allograft
bptb
acl
reconstruct
final
retrospect
studi
restor
propriocept
acl
reconstruct
bptb
autograft
allograft
conduct
ozenc
et
al
compar
four
group
subject
includ
acl
defici
autograft
reconstruct
allograft
reconstruct
patient
healthi
control
auto
allograft
reconstruct
differ
control
accord
propriocept
measur
also
report
propriocept
correl
postop
anterior
knee
laxiti
although
studi
retrospect
select
natur
rel
small
number
patient
conclud
auto
allograft
acl
reconstruct
ident
accord
propriocept
function
acl
reconstruct
usual
procedur
sport
medicin
orthopedist
today
autograft
specif
golden
standard
bptb
hamstr
tendon
goodtoexcel
result
term
knee
stabil
patient
satisfact
return
athlet
activ
howev
autograft
especi
bptb
could
caus
specif
donorsit
morbid
allograft
becom
altern
option
allograft
advantag
donorsit
morbid
shorter
oper
time
small
incis
easier
possibl
less
pain
rehabilit
size
restrict
howev
question
remain
concern
actual
risk
infect
diseas
transmiss
implant
even
signific
progress
screen
process
steril
techniqu
risk
elimin
addit
use
allograft
tissu
one
must
awar
may
gener
lowlevel
immun
respons
also
report
allograft
delay
embodi
time
greater
cost
mechan
biolog
steril
process
allograft
tissu
remain
unknown
overal
choic
graft
materi
depend
surgeon
patient
prefer
sinc
graft
match
complet
biomechan
properti
function
nativ
acl
